# Amparo Sole Jover, M.D. – FDA Inspection, Nov 17, 2017

Source: https://www.keypedia.com/records/fda_inspections/amparo-sole-jover-md/9ae39a6a-19ae-40fd-a16f-4a7655940707
Source feed: FDA_Inspections

> FDA inspection 1036625 of Amparo Sole Jover, M.D., November 17, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1036625
- Company Name: Amparo Sole Jover, M.D.
- Inspection Date: 2017-11-17
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/ethan-p-stegman/a2bd07b8-1289-4d95-a362-7a95aa6708c9)

Company: https://www.keypedia.com/companies/amparo-sole-jover-md/e219e6e4-9054-4e90-b248-306713fd5fd6

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c